Apoha, a startup using building AI based on new liquid 'wave form' data, emerges from stealth with $36 million Series A round | Fortune

Apoha, a startup using building AI based on new liquid 'wave form' data, emerges from stealth with $36…

Apoha raises $36M Series A for AI models trained on wave-form material data to predict drug efficacy in pharma and biotech. For tech leaders, this marks AI's expansion into scientific R&D: 90% accuracy pre-trial screening saves pharma hundreds of millions per failed candidate and accelerates time-to-market.